000 | 01353 a2200409 4500 | ||
---|---|---|---|
005 | 20250514065912.0 | ||
264 | 0 | _c20030623 | |
008 | 200306s 0 0 eng d | ||
022 | _a1422-2795 | ||
024 | 7 |
_a10.1159/000064194 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoldrup, Claus | |
245 | 0 | 0 |
_aEthical, social and legal implications of pharmacogenomics: a critical review. _h[electronic resource] |
260 |
_bCommunity genetics _c2001 |
||
300 |
_a204-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAttitude |
650 | 0 | 4 | _aBeneficence |
650 | 0 | 4 |
_aControlled Clinical Trials as Topic _xeconomics |
650 | 0 | 4 |
_aDrug Industry _xeconomics |
650 | 0 | 4 | _aGenetic Privacy |
650 | 0 | 4 | _aGenetic Testing |
650 | 0 | 4 | _aGovernment Agencies |
650 | 0 | 4 | _aHealth Care Costs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInformed Consent |
650 | 0 | 4 | _aOrphan Drug Production |
650 | 0 | 4 | _aPersonal Autonomy |
650 | 0 | 4 |
_aPharmaceutical Preparations _xeconomics |
650 | 0 | 4 |
_aPharmacogenetics _xeconomics |
650 | 0 | 4 | _aPrejudice |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSocial Justice |
773 | 0 |
_tCommunity genetics _gvol. 4 _gno. 4 _gp. 204-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000064194 _zAvailable from publisher's website |
999 |
_c12539675 _d12539675 |